![Casper Hansen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Casper Hansen
Vorstandsvorsitzender bei
Embark Laboratories ApS
Profil
Casper Tind Hansen founded Churney ApS in 2021.
Dr. Hansen also currently works at Pcovery ApS, as Chief Executive Officer & Director from 2013 and Embark Laboratories ApS, as Chief Executive Officer & Director from 2023.
Dr. Hansen also formerly worked at Novo Nordisk Research Center Gladsaxe ApS, as Chief Executive Officer & Director, Adenium Biotech ApS, as Director, H.
Lundbeck A, as Head-Marketing, Takeda A, as Senior Market Analyst, and Novo Ventures 1 A, as Principal in 2013.
Dr. Hansen received his graduate degree from the University of Copenhagen.
Aktive Positionen von Casper Hansen
| Unternehmen | Position | Beginn |
|---|---|---|
Embark Laboratories ApS
 Embark Laboratories ApS BiotechnologyHealth Technology Operates as a biotech company that focuses on cardiometabolic disease | Vorstandsvorsitzender | 07.05.2023 |
Ehemalige bekannte Positionen von Casper Hansen
| Unternehmen | Position | Ende |
|---|---|---|
Embark Biotech ApS
 Embark Biotech ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development on biotechnology, natural sciences and engineering services | Vorstandsvorsitzender | 29.08.2023 |
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements. | Corporate Officer/Principal | 01.01.2013 |
Churney ApS
 Churney ApS Data Processing ServicesTechnology Services Automates LTV analytics | Gründer | - |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Corporate Officer/Principal | - |
Pcovery ApS
 Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections | Vorstandsvorsitzender | - |
Ausbildung von Casper Hansen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures invests in companies located in Europe, the United States and Asia. The firm targets companies operating in the fields of health technology, health services, biotechnology and medical specialties sectors. It provides financing for early stage capital requirements. | Finance |
Pcovery ApS
Pcovery ApS Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of invasive fungal infections | Health Technology |
Adenium Biotech ApS
 Adenium Biotech ApS Pharmaceuticals: MajorHealth Technology Provides novel antibiotics for the treatment of multi drug resistant bacterial infections | Health Technology |
Embark Biotech ApS
Embark Biotech ApS Miscellaneous Commercial ServicesCommercial Services Engages in research and development on biotechnology, natural sciences and engineering services | Commercial Services |
Embark Laboratories ApS
Embark Laboratories ApS BiotechnologyHealth Technology Operates as a biotech company that focuses on cardiometabolic disease | Health Technology |
Churney ApS
Churney ApS Data Processing ServicesTechnology Services Automates LTV analytics | Technology Services |
